Optivia Biotechnology (United States)

Recent papers from Optivia Biotechnology (United States)

1. 102P Sustained response and long-term therapeutic benefits beyond treatment cessation in NSCLC relapsed-patients treated with ateganosine and ICI in the THIO-101 trialESMO Open · 2026
2. Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1)Journal of Medicinal Chemistry · 2017
3. Lack of Interactions Between an Antisense Oligonucleotide with 2′- O -(2-Methoxyethyl) Modifications and Major Drug TransportersNucleic Acid Therapeutics · 2016
4. Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistatKidney International · 2014
5. Site-Specific Labeling of a Protein Lysine Residue by Novel Kinetic Labeling Combinatorial LibrariesComputational and Structural Biotechnology Journal · 2014
6. High-Level Pacidamycin Resistance in Pseudomonas aeruginosa Is Mediated by an Opp Oligopeptide Permease Encoded by the opp-fabI OperonAntimicrobial Agents and Chemotherapy · 2013
7. Discovery of Potent, Selective Multidrug and Toxin Extrusion Transporter 1 (MATE1, SLC47A1) Inhibitors Through Prescription Drug Profiling and Computational ModelingJournal of Medicinal Chemistry · 2012
8. Interactions of bilastine, a new oral H₁antihistamine, with human transporter systemsDrug and Chemical Toxicology · 2012
9. Permanent Inhibition of Viral Entry by Covalent Entrapment of HIV gp41 on the Virus SurfaceBiochemistry · 2011
10. Mechanism of the sulfurisation of phosphines and phosphites using 3-amino-1,2,4-dithiazole-5-thione (xanthane hydride)Organic & Biomolecular Chemistry · 2007
11. Multiple analysis of an unknown optical multilayer coatingApplied Optics · 1985